Literature DB >> 26243757

Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: Association with migraine characteristics.

Mustafa Ceylan1, Omer Faruk Bayraktutan1, Sinan Becel2, Ömer Atis3, Ahmet Yalcin4, Dilcan Kotan5.   

Abstract

BACKGROUND: Several studies have been conducted on the inflammatory aspects of migraine. Pentraxins are a novel and important part of innate immunity as a superfamily of acute phase proteins. In our study, we aimed to demonstrate the relationship between migraine and the serum levels of pentraxin-3 (PTX-3), C-reactive protein (CRP), fibrinogen and D-dimer.
METHODS: We recruited 30 migraine patients (in both the attack and interictal period) and 30 healthy controls. Serum samples were obtained from all participants, and a brain MRI performed in the last six months was assessed regarding the presence of deep white matter lesions. Comparisons between the attack, interictal and control groups regarding the serum levels of PTX-3, CRP, fibrinogen and D-dimer were performed. The association between serum PTX-3 levels and migraine characteristics (disease duration, headache frequency, MRI findings, aura, family history, attack duration, and MIDAS score) was also assessed.
RESULTS: We found higher serum levels of fibrinogen and PTX-3 in migraine attack patients compared with the interictal and control groups (p = 0.03 and p < 0.001, respectively). Subgroup analysis also showed that patients with a disease duration of more than five years and with an attack duration of more than 12 hours have lower serum levels of PTX-3 than patients who have a relatively new diagnosis and have relatively short-lasting migraine attacks (p = 0.042 and p = 0.038, respectively).
CONCLUSIONS: PTX-3 and fibrinogen exhibit different serum levels in patients undergoing a migraine attack compared with the interictal group and the controls. Participants with longer attacks and disease durations have lower serum levels of PTX-3, suggesting that inflammatory processes change along with disease progression. © International Headache Society 2015.

Entities:  

Keywords:  C-reactive protein; D-dimer; Migraine; fibrinogen; pentraxin-3

Mesh:

Substances:

Year:  2015        PMID: 26243757     DOI: 10.1177/0333102415598757

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

1.  Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs.

Authors:  Yago Leira; Pablo Ameijeira; Clara Domínguez; Esteban López-Arias; Paulo Ávila-Gómez; María Pérez-Mato; Tomás Sobrino; Francisco Campos; Francesco D'Aiuto; Rogelio Leira; Juan Blanco
Journal:  Clin Oral Investig       Date:  2019-05-20       Impact factor: 3.573

Review 2.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

3.  The Effect of Nano-Curcumin Supplementation on Pentraxin 3 Gene Expression and Serum Level in Migraine Patients.

Authors:  Mona Djalali; Mahmoud Djalali; Mina Abdolahi; Hamed Mohammadi; Hajar Heidari; Shayesteh Hosseini; Majid Sadeghizadeh
Journal:  Rep Biochem Mol Biol       Date:  2020-04

4.  Roxadustat alleviates nitroglycerin-induced migraine in mice by regulating HIF-1α/NF-κB/inflammation pathway.

Authors:  Dai-Gang Yang; Yong-Yao Gao; Ze-Qun Yin; Xue-Rui Wang; Xian-She Meng; Ting-Feng Zou; Ya-Jun Duan; Yuan-Li Chen; Chen-Zhong Liao; Zhou-Ling Xie; Xiao-Dong Fan; Lu Sun; Ji-Hong Han; Xiao-Xiao Yang
Journal:  Acta Pharmacol Sin       Date:  2022-08-10       Impact factor: 7.169

5.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

6.  The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Authors:  Fahimeh Martami; Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Maryam Seifishahpar; Atoosa Saidpour
Journal:  Neurol Sci       Date:  2018-07-15       Impact factor: 3.307

7.  Accumulation of α-Synuclein in Cerebellar Purkinje Cells of Diabetic Rats and Its Potential Relationship with Inflammation and Oxidative Stress Markers.

Authors:  Volkan Solmaz; Hatice Köse Özlece; Hüseyin Avni Eroglu; Hüseyin Aktuğ; Oytun Erbaş; Dilek Taşkıran
Journal:  Neurol Res Int       Date:  2017-01-04

8.  Increased Risk of Migraine in Patients with Chronic Periodontitis: A Population-Based Cohort Study.

Authors:  Yung-Kai Huang; Li-Chiu Yang; Yu-Hsun Wang; Yu-Chao Chang
Journal:  Int J Environ Res Public Health       Date:  2021-02-17       Impact factor: 3.390

9.  Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial.

Authors:  Reza Ganji; Nastaran Majdinasab; Saeed Hesam; Nazanin Rostami; Mehdi Sayyah; Adeleh Sahebnasagh
Journal:  J Pharm Health Care Sci       Date:  2021-04-01

10.  The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.

Authors:  Zeinab Ghorbani; Pegah Rafiee; Akbar Fotouhi; Samane Haghighi; Reyhaneh Rasekh Magham; Zeynab Sadat Ahmadi; Mahmoud Djalali; Mahnaz Zareei; Soodeh Razeghi Jahromi; Sahar Shahemi; Maryam Mahmoudi; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-24       Impact factor: 7.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.